top of page
Background_Elements-02.png

ViAqua Therapeutics Ltd.

ViAqua Therapeutics Ltd.

About Us

ViAqua Therapeutics addresses the growing need for effective and affordable health management solutions for aquaculture. ViAqua’s 1st product is a novel oral delivery platform designed to deliver RNA. Co-developed with Skretting (a Nutreco company), RNA induced resistance to White Spot Shrimp Virus is incorporated into and delivered by shrimp-feed.

Sector:

Shellfish

Year Founded:

2014

Investment Stage:

Seed

bottom of page